Supernus Pharmaceuticals, Inc. (LON:0LB2)
London · Delayed Price · Currency is GBP · Price in USD 44.40
+0.58 (1.32%)
At close: Sep 17, 2025
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 674 employees as of December 31, 2024. The number of employees increased by 22 or 3.37% compared to the previous year.
Employees
674
Change (1Y)
22
Growth (1Y)
3.37%
Revenue / Employee
720.29K GBP
Profits / Employee
69.85K GBP
Market Cap
1.84B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 674 | 22 | 3.37% |
| Dec 31, 2023 | 652 | 40 | 6.54% |
| Dec 31, 2022 | 612 | 37 | 6.43% |
| Dec 31, 2021 | 575 | 12 | 2.13% |
| Dec 31, 2020 | 563 | 99 | 21.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Supernus Pharmaceuticals News
- 21 days ago - Supernus Pharmaceuticals to Participate in September Investor Conferences - GlobeNewsWire
- 4 weeks ago - Insider Decision: Frederick Hudson Offloads $315K Worth Of Supernus Pharmaceuticals Stock - Benzinga
- 5 weeks ago - Supernus Pharmaceuticals Stock Scores RS Rating Upgrade - Investor's Business Daily
- 6 weeks ago - Supernus Pharmaceuticals, Inc. (SUPN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Supernus Pharmaceuticals GAAP EPS of $0.40 beats by $0.46, revenue of $165.5M beats by $11.42M - Seeking Alpha
- 6 weeks ago - Supernus Announces Second Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics - GlobeNewsWire
- 7 weeks ago - Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer - GlobeNewsWire